Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    Author Review: Xiaohui Sun (critical, evidence-based)
    Based only on the papers list and extracted technical summaries you provided, Xiaohui Sun’s visible scientific footprint spans (i) tumor immunology / glioblastoma microenvironment (including a later correction) and (ii) mechanistic cell biology / molecular kinetics (translation initiation), plus (iii) a narrative neuro review, and (iv) an eye/cataract mechanism study that was subsequently retracted. Taken together, this profile shows periods of strong mechanistic measurement and causal testing, alongside nontrivial reproducibility/data-integrity risk signals.
    Key caution: your OpenAlex snippet does not uniquely identify Xiaohui Sun (it contains multiple “Xiaohui Sun” matches and one high-citation “Xiaohui Fan” with astronomy topics), so assignment-by-name is uncertain.



     Long Explanation


    Author Review (Skeptical & Evidence-Graded): Xiaohui Sun
    Date context: April 26, 2026. Evidence scope: only the author-related items and extracted study metadata you supplied (OpenAlex snippet + paper excerpts). No extra bibliographic lookup was possible from the prompt inputs.
    1) Evidence map (what’s visible from your provided data)
    • Glioblastoma immunology (microglia/macrophage programming): CMTM6 drives glioblastoma progression... (European Journal of Medical Research; dated Oct 27, 2025), with an extracted mechanistic pipeline (multi-omics, IHC/IF localization, in vitro knockdown/co-culture, and microglia/macrophage-specific inducible knockout in an orthotopic GL261 model). A later item is listed as a correction (dated Mar 6, 2026). Input-provided DOI: 10.1186/s40001-025-03243-6 and correction DOI: 10.1186/s40001-026-03917-9.
    • Translation initiation kinetics (single-molecule assay): An in vitro single-molecule assay for eukaryotic cap-dependent translation initiation kinetics (Nucleic Acids Research; dated Nov 13, 2019). Extracted details emphasize TIRF-based single-molecule trajectories, first-arrival initiation readout, dwell-time elongation readout, and reported elongation rate ~2.5 aa/s.
    • Neuro receptor signaling synthesis: NMDARs regulate the excitatory-inhibitory balance within neural circuits (Brain Science Advances; dated Feb 27, 2023). Extracted to be a narrative literature review (no primary experiments).
    • Cataracts & pyroptosis & blue light: two linked items from BMC Ophthalmology—(i) a primary study DOI 10.1186/s12886-020-01565-z (dated July 15, 2020) and (ii) a retraction note DOI 10.1186/s12886-022-02416-9 dated Apr 26, 2022, citing data integrity concerns.
    2) Visual evidence grading from your provided paper scores
    The plot below uses only the numeric “paper_*_score” values you provided per item. (These are not peer-review scores; they are your extracted/assigned rubric outputs.)
    3) Methodological & evidence-strength critique (paper-by-paper)
    3.1 CMTM6 in glioblastoma (microglia/macrophages) — strong mechanistic arc, but correction flags interpretation risk
    Core claim (from your extracted summary): CMTM6 is enriched in M2-like glioblastoma-associated microglia/macrophages (GAMs), correlates with PD-L1 immune evasion, and microglia/macrophage-specific Cmtm6 deletion (inducible, Cx3cr1CreERT2/+; Cmtm6fl/fl) suppresses tumor growth and extends survival in an orthotopic GL261 model; the study argues CMTM6 reprograms myeloid phenotype toward immunosuppression. Input DOI: 10.1186/s40001-025-03243-6.
    • Strengths (evidence stack) (from your extracted metadata): multi-omics across public bulk and single-cell resources (TCGA/CGGA; TISCH2/UCSC), localization by IHC/IF in tissue, and both in vitro knockdown/co-culture and in vivo conditional knockout plus imaging and Kaplan–Meier survival. This is a relatively complete mechanism-to-phenotype pipeline.
    • Weaknesses / uncertainty: your extracted limitations emphasize reliance on HMC3 (a cell line) and GL261 (species/model mismatch), possible incompleteness/off-target recombination in cell-type targeting, and unclear breadth of immune-cell mechanistic dissection beyond myeloid cells (limited T-cell/astrocyte roles).
    • Reproducibility / interpretability risk: a later correction entry is provided (input DOI 10.1186/s40001-026-03917-9). Your extracted correction metadata notes that the correction of Figure 3 suggests potential prior misinterpretation. Even if corrected, this reduces confidence in any downstream causal claims until the corrected figure-level details are verified.
    Confidence calibration (based only on your extracted notes): moderate-to-high mechanistic plausibility, but with nontrivial epistemic risk due to correction and model limitations.
    3.2 Single-molecule assay for cap-dependent translation kinetics — high measurement resolution, good general-purpose utility
    Core claim (from your extracted summary): a TIRF-based assay tracks antibody binding to nascent 3xFLAG peptides to quantify initiation kinetics (first-arrival time) and elongation kinetics (dwell time), reporting substantial mRNA-to-mRNA initiation asynchrony and an elongation rate ~2.5 aa/s; the method works in multiple cell-free extracts (yeast extract, wheat germ extract, rabbit reticulocyte lysate). Input DOI: 10.1093/nar/gkz1066.
    • Strengths: the extracted design is explicitly quantitative at single-molecule scale, uses large numbers of trajectories (e.g., thousands of first-arrival events in YE; specific n-values are included in your input), and connects two mechanistic stages (initiation vs elongation) with distinct readouts.
    • Internal consistency: your extracted “limitations” mention whether antibody binding could be rate-limiting; the authors (per your extraction) address this by controlling conditions and using CHX stalling where appropriate, plus drift/background correction and event detection with model-based fitting.
    • Transferability caveats: cell-free systems may not replicate in vivo regulatory complexity; surface immobilization and labeling can introduce artifacts; polysome/monosome state may complicate interpretations. These are standard and appropriately acknowledged concerns.
    Confidence calibration: high on measurement logic (because your extracted details specify large n and mechanistically distinct readouts), but still moderate on physiological extrapolation.
    3.3 Narrative review on NMDAR regulation of excitatory–inhibitory balance — synthesis value, but not causal evidence
    Core claim (from your extracted summary): NMDA receptor signaling coordinates excitatory–inhibitory balance by modulating AMPAR trafficking and GABAA receptor dynamics/clustering, with downstream implications for neurodevelopmental and neuropsychiatric disorders. Input DOI: 10.26599/bsa.2022.9050020.
    • Appropriate role: as a narrative literature review, it can map mechanisms and propose integration, but it cannot, by itself, establish causality or quantify effect sizes.
    • Key blind spots (from your extraction): selection bias (which studies are included), cross-species overgeneralization, and dependence on heterogeneous methodologies without a systematic meta-analytic correction for study-level biases.
    Confidence calibration: moderate as a mechanistic overview; low for claims that require direct experimental causal validation from the review itself.
    3.4 Blue-light cataracts & pyroptosis — major negative signal due to retraction
    Core claim (from your extracted summary of the original study): short-wavelength blue light induces cataracts in rats and activates pyroptosis pathways (caspase-1/caspase-11/GSDMD) in rat lens epithelial cells; caspase-1 inhibition reduced pyroptosis readouts. Original DOI: 10.1186/s12886-020-01565-z.
    But: a retraction note is explicitly included (dated Apr 26, 2022) with data integrity concerns (non-representative flow plots, Western blot images not matching quantification, and issues distinguishing pyroptosis from apoptosis). Retraction DOI: 10.1186/s12886-022-02416-9.
    • Why this matters scientifically: a retraction is a high-weight signal about trustworthiness of results; it often invalidates specific mechanistic interpretations in the retracted article even if parts of the broader field remain true.
    • Consequence for author assessment: it is reasonable to downgrade confidence in the author’s research operations for this specific line and period, because the extracted justification cites concrete presentation/analysis problems rather than only “novelty or disagreement.”
    • What remains unknown: retraction notes typically do not quantify how many downstream claims are affected; verification would require the unambiguous content of the retraction report and any subsequent corrected/independent replications.
    Confidence calibration: for the retracted paper’s causal mechanism claim, low confidence based on the retraction rationale alone.
    4) Correlation-style visual: (provided) reproducibility vs explanation depth
    A compact view of how your extracted rubric pairs “reproducibility score” with “explanatory depth score”. (This is rubric-derived; interpret cautiously.)
    5) Critical synthesis: what your provided evidence suggests about scientific strength
    Most defensible signal: the single-molecule translation kinetics paper (2019) is structured around quantitative, mechanistically separable observables (initiation vs elongation) with large trajectory counts in multiple extract systems—this is the most “measurement-forward” and (from your extraction) method-translatable item. Input DOI: 10.1093/nar/gkz1066.
    Second signal: the GBM/CMTM6 pipeline contains multiple evidence modalities and ends with cell-type-specific functional perturbation in vivo; however, the existence of a separate correction item and the extracted model/cell-line/species limitations reduce confidence in the exact magnitude of claims and in how broadly the mechanism generalizes. Input DOIs: 10.1186/s40001-025-03243-6 and 10.1186/s40001-026-03917-9.
    Strong negative signal: the blue-light/cataract work has an explicit retraction note citing data integrity and presentation/analysis inconsistencies. That is a major credibility downgrade for that specific study’s mechanistic conclusions. Input DOIs: 10.1186/s12886-020-01565-z and 10.1186/s12886-022-02416-9.
    Important identification uncertainty (name disambiguation)
    Your OpenAlex snippet includes multiple distinct “Xiaohui Sun” records plus a top-author entry labeled “Xiaohui Fan” with different topic distributions (astronomy/quasar) and very different citation metrics. Because the prompt does not provide article-to-author linkage (e.g., ORCID, affiliation, or full author list mapping) for the biological papers above, attribution to “Xiaohui Sun” is uncertain. This uncertainty limits how confidently we can infer an author’s global scientific ability from these selected items.
    Where the evidence is likely incomplete / misleading
    • Selection bias: you provided only a handful of items; absent the rest of the author’s portfolio, the assessment may overweigh outliers (one retraction, one high-performing method paper).
    • Rubric mismatch risk: the provided numeric “paper_*_scores” are not defined in the prompt; they may reflect subjective grading rather than standardized metrics.
    • Correction vs primary causality: a correction may change figure interpretation but not necessarily invalidate the entire mechanistic chain; conversely it can. Without the corrected text/figures, uncertainty remains.


    Feedback:    

    Updated: April 26, 2026

     Top Data Sources ExportMCP


     Science Art


    Author Review: Xiaohui Sun Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending